tm logo
CELLISTIC
Live/Pending
PUBLICATION/ISSUE REVIEW COMPLETE

on 10 Apr 2024

Last Applicant/ Owned by

Galileiweg 8

LEIEN

NL

2333B

Serial Number

97301281 filed on 08th Mar 2022

Registration Number

N/A

Correspondent Address

Roberto LedesmaLAW OICE O ROBERTO LEESMA

P.O. BOX 230692

NEW YORK,NY

10023

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

CELLISTIC

Laboratory research in the field of biopharmaceuticals; laboratory research in the field of biotechnology; biotechnology research and testing, namely, testing of pharmaceuticals; development of new technology for others in the field of biotechnology; scientific research on stem cells; scientific research on the production and differentiation of pluripotent stem cells; research and development in tRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Laboratory research in the field of biopharmaceuticals; laboratory research in the field of biotechnology; biotechnology research and testing, namely, testing of pharmaceuticals; development of new technology for others in the field of biotechnology; scientific research on stem cells; scientific research on the production and differentiation of pluripotent stem cells; research and development in the field of stem cells, cell therapy pharmaceuticals and biotechnology; pharmaceutical research and development; scientific laboratory services; providing information with respect to scientific research in the field of stem cells, cell and gene therapy and biotechnology; research and development for the pharmaceutical industry; Technological consultancy services in the field of biotechnology; technological consulting services in the pharmaceutical industry; graphic design services; graphic design services for the pharmaceutical industry; industrial analysis of biopharmaceutical products to assure compliance with industry standards and research services in the field of biopharmaceuticals; biopharmaceutical research and development; research and development of new products for others; product development consultation; scientific consultancy services in the fields of biotechnology products, pharmaceutical products, medical products; scientific consultancy services for the pharmaceutical industry, namely, in the field of pharmaceutical research

Class [009]
Computer & Software Products & Electrical & Scientific Products


Scientific apparatus and instruments, namely, instruments for cell characterization in the nature of imagers being image scanners, flow cytometers, nucleic acid sequencers for scientific purposes; cell culture apparatus for laboratory use, namely, cell sorting devices, cell culture dishes, tissue culture flasks; bioreactors for cell culturing for scientific research; bioreactors for laboratory use; bioreactors for cell culturing for scientific research use; bioreactors for cell culturing for scientific research use, namely, for cell therapy pharmaceuticals manufacturing

Class [007]
Machinery Products


bioreactors for use in manufacturing biopharmaceuticals, namely, cell therapy pharmaceuticals

Class [040]
Treatment & Processing of Materials Services


Custom manufacture of biopharmaceuticals; Treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of biopharmaceuticals and cell therapy pharmaceuticals; manufacture of cell therapy pharmaceuticals to the order and/or specification of others

Mark Details


Serial Number

No 97301281

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
24th Apr 2024NOTIICATION O NOTICE O PUBLICATION E-MAILE
08th Apr 2024APPROVE OR PUB - PRINCIPAL REGISTER
29th Mar 2024TEAS RESPONSE TO OICE ACTION RECEIVE
29th Mar 2024TEAS/EMAIL CORRESPONENCE ENTERE
29th Mar 2024CORRESPONENCE RECEIVE IN LAW OICE
05th Feb 2024NOTIICATION O NON-INAL ACTION E-MAILE
05th Feb 2024NON-INAL ACTION E-MAILE
05th Feb 2024NON-INAL ACTION WRITTEN
30th Dec 2023TEAS/EMAIL CORRESPONENCE ENTERE
29th Dec 2023CORRESPONENCE RECEIVE IN LAW OICE